How does the TNM system describe the spread of pancreatic cancer?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

An anatomical illustration of the human pancreas shows its location near the stomach and intestines, a detailed cross-section highlighting ducts and the islet of Langerhans, and an inset of pancreatic tissue histology with labeled alpha, beta, and delta cells. — pancreatic cancer The human pancreas is composed of two main types of tissue: acinar cells and islets of Langerhans. The acinar cells produce digestive enzymes, which are secreted into tiny ducts that feed into the pancreatic duct. Islets of Langerhans are clusters of cells that secrete hormones such as insulin and glucagon directly into a capillary network, which also joins the pancreatic duct.

The TNM staging system is an internationally recognized method used to describe the extent and spread of cancer. In the context of pancreatic cancer, this system evaluates the disease based on three specific criteria:

T (Tumor): Describes the size and local extent of the primary tumor within the pancreas.
N (Nodes): Indicates whether the cancer has spread to regional lymph nodes and the extent of that involvement.
M (Metastasis): Denotes whether the cancer has metastasized, or spread, to distant organs or tissues beyond the pancreas.

By assessing these factors, clinicians can determine the stage of the cancer, which is essential for predicting tumor behavior, establishing a prognosis, and selecting the most appropriate treatment plan.1